Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Marine Chemistry|January 1, 1991
Method for determining stable isotope ratios of dissolved organic carbon in interstitial and other natural marine watersJ E Bauer, R I Haddad, D J Des Marais
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 11, 2018
Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: role, controversy, and future directionsR I Haddad, M Posner, R Hitt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2011
Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trialM R Posner, J H Lorch, O Goloubeva, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2018
Plasma HPV cell-free DNA monitoring in advanced HPV-associated oropharyngeal cancerG J Hanna, J G Supplee, Y Kuang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 20, 2012
Treatment of oropharyngeal squamous cell carcinoma with IMRT: patterns of failure after concurrent chemoradiotherapy and sequential therapyD J Sher, V Thotakura, T A Balboni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2009
Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neckL J Wirth, A M Allen, M R Posner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2024
Duvelisib with Docetaxel for Patients with Anti-PD-1 Refractory, Recurrent, or Metastatic Head and Neck Squamous Cell CarcinomaGlenn J Hanna, L B Oakley, R Shi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 17, 2016
Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: subgroup analysis of the LUX-Head & Neck 1 trialP M Clement, T Gauler, J P Machiels, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancerE E W Cohen, L F Licitra, B Burtness, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 2019
Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinomaR I Haddad, E Massarelli, J J Lee, et al.
Pageof 2